1 Recombinant Vaccines Market Overview |
|
1.1 Product Overview and Scope of Recombinant Vaccines |
|
1.2 Recombinant Vaccines Segment by Type |
|
| 1.2.1 Global Recombinant Vaccines Sales Growth Rate Comparison by Type (2021-2026) | |
| 1.2.2 Subunit Recombinant Vaccines | |
| 1.2.3 Attenuated Recombinant Vaccines | |
| 1.2.4 Vector Recombinant Vaccines | |
1.3 Recombinant Vaccines Segment by Application |
|
| 1.3.1 Recombinant Vaccines Sales Comparison by Application: 2020 VS 2026 | |
| 1.3.2 Recombinant Human Vaccines | |
| 1.3.3 Animal Recombinant Vaccines | |
1.4 Global Recombinant Vaccines Market Size Estimates and Forecasts |
|
| 1.4.1 Global Recombinant Vaccines Revenue 2015-2026 | |
| 1.4.2 Global Recombinant Vaccines Sales 2015-2026 | |
| 1.4.3 Recombinant Vaccines Market Size by Region: 2020 Versus 2026 | |
2 Global Recombinant Vaccines Market Competition by Manufacturers |
|
2.1 Global Recombinant Vaccines Sales Market Share by Manufacturers (2015-2020) |
|
2.2 Global Recombinant Vaccines Revenue Share by Manufacturers (2015-2020) |
|
2.3 Global Recombinant Vaccines Average Price by Manufacturers (2015-2020) |
|
2.4 Manufacturers Recombinant Vaccines Manufacturing Sites, Area Served, Product Type |
|
2.5 Recombinant Vaccines Market Competitive Situation and Trends |
|
| 2.5.1 Recombinant Vaccines Market Concentration Rate | |
| 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue | |
| 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) | |
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans |
|
2.7 Primary Interviews with Key Recombinant Vaccines Players (Opinion Leaders) |
|
3 Recombinant Vaccines Retrospective Market Scenario by Region |
|
3.1 Global Recombinant Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 |
|
3.2 Global Recombinant Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 |
|
3.3 North America Recombinant Vaccines Market Facts & Figures by Country |
|
| 3.3.1 North America Recombinant Vaccines Sales by Country | |
| 3.3.2 North America Recombinant Vaccines Sales by Country | |
| 3.3.3 U.S. | |
| 3.3.4 Canada | |
3.4 Europe Recombinant Vaccines Market Facts & Figures by Country |
|
| 3.4.1 Europe Recombinant Vaccines Sales by Country | |
| 3.4.2 Europe Recombinant Vaccines Sales by Country | |
| 3.4.3 Germany | |
| 3.4.4 France | |
| 3.4.5 U.K. | |
| 詳^情：http://www.qdlaimaiche.com/0/69/2020-2026-Global-Recombinant-Vaccines-Market-In-Depth-Research-and-Trends-Analysis-Repor.html | |
| 3.4.6 Italy | |
| 3.4.7 Russia | |
3.5 Asia Pacific Recombinant Vaccines Market Facts & Figures by Region |
|
| 3.5.1 Asia Pacific Recombinant Vaccines Sales by Region | |
| 3.5.2 Asia Pacific Recombinant Vaccines Sales by Region | |
| 3.5.3 China | |
| 3.5.4 Japan | |
| 3.5.5 South Korea | |
| 3.5.6 India | |
| 3.5.7 Australia | |
| 3.5.8 Taiwan, China | |
| 3.5.9 Indonesia | |
| 3.5.10 Thailand | |
| 3.5.11 Malaysia | |
| 3.5.12 Philippines | |
| 3.5.13 Vietnam | |
3.6 Latin America Recombinant Vaccines Market Facts & Figures by Country |
|
| 3.6.1 Latin America Recombinant Vaccines Sales by Country | |
| 3.6.2 Latin America Recombinant Vaccines Sales by Country | |
| 3.6.3 Mexico | |
| 3.6.3 Brazil | |
| 3.6.3 Argentina | |
3.7 Middle East and Africa Recombinant Vaccines Market Facts & Figures by Country |
|
| 3.7.1 Middle East and Africa Recombinant Vaccines Sales by Country | |
| 3.7.2 Middle East and Africa Recombinant Vaccines Sales by Country | |
| 3.7.3 Turkey | |
| 3.7.4 Saudi Arabia | |
| 3.7.5 U.A.E | |
4 Global Recombinant Vaccines Historic Market Analysis by Type |
|
4.1 Global Recombinant Vaccines Sales Market Share by Type (2015-2020) |
|
4.2 Global Recombinant Vaccines Revenue Market Share by Type (2015-2020) |
|
4.3 Global Recombinant Vaccines Price Market Share by Type (2015-2020) |
|
4.4 Global Recombinant Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End |
|
5 Global Recombinant Vaccines Historic Market Analysis by Application |
|
5.1 Global Recombinant Vaccines Sales Market Share by Application (2015-2020) |
|
5.2 Global Recombinant Vaccines Revenue Market Share by Application (2015-2020) |
|
5.3 Global Recombinant Vaccines Price by Application (2015-2020) |
|
6 Company Profiles and Key Figures in Recombinant Vaccines Business |
|
6.1 Company 1 |
|
| 6.1.1 Corporation Information | |
| 6.1.2 Company 1 Description, Business Overview and Total Revenue | |
| 6.1.3 Company 1 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.1.4 Company 1 Products Offered | |
| 6.1.5 Company 1 Recent Development | |
6.2 Company 2 |
|
| 6.2.1 Company 2 Recombinant Vaccines Production Sites and Area Served | |
| 6.2.2 Company 2 Description, Business Overview and Total Revenue | |
| 6.2.3 Company 2 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.2.4 Company 2 Products Offered | |
| 6.2.5 Company 2 Recent Development | |
6.3 Company 3 |
|
| 6.3.1 Company 3 Recombinant Vaccines Production Sites and Area Served | |
| 6.3.2 Company 3 Description, Business Overview and Total Revenue | |
| 6.3.3 Company 3 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.3.4 Company 3 Products Offered | |
| 6.3.5 Company 3 Recent Development | |
6.4 Company 4 |
|
| 6.4.1 Company 4 Recombinant Vaccines Production Sites and Area Served | |
| 6.4.2 Company 4 Description, Business Overview and Total Revenue | |
| 6.4.3 Company 4 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.4.4 Company 4 Products Offered | |
| 6.4.5 Company 4 Recent Development | |
6.5 Company 5 |
|
| 6.5.1 Company 5 Recombinant Vaccines Production Sites and Area Served | |
| 6.5.2 Company 5 Description, Business Overview and Total Revenue | |
| 6.5.3 Company 5 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.5.4 Company 5 Products Offered | |
| 6.5.5 Company 5 Recent Development | |
6.6 Company 6 |
|
| 6.6.1 Company 6 Recombinant Vaccines Production Sites and Area Served | |
| 6.6.2 Company 6 Description, Business Overview and Total Revenue | |
| 6.6.3 Company 6 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.6.4 Company 6 Products Offered | |
| 6.6.5 Company 6 Recent Development | |
6.7 Company 7 |
|
| 6.6.1 Company 7 Recombinant Vaccines Production Sites and Area Served | |
| 6.6.2 Company 7 Description, Business Overview and Total Revenue | |
| 6.6.3 Company 7 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.4.4 Company 7 Products Offered | |
| 6.7.5 Company 7 Recent Development | |
6.8 Company 8 |
|
| 二〇二〇年至2026年全球重組疫苗市場的深入研究和趨勢分析報告 | |
| 6.8.1 Company 8 Recombinant Vaccines Production Sites and Area Served | |
| 6.8.2 Company 8 Description, Business Overview and Total Revenue | |
| 6.8.3 Company 8 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.8.4 Company 8 Products Offered | |
| 6.8.5 Company 8 Recent Development | |
6.9 Company 9 |
|
| 6.9.1 Company 9 Recombinant Vaccines Production Sites and Area Served | |
| 6.9.2 Company 9 Description, Business Overview and Total Revenue | |
| 6.9.3 Company 9 Recombinant Vaccines Sales, Revenue and Gross Margin (2015-2020) | |
| 6.9.4 Company 9 Products Offered | |
| 6.9.5 Company 9 Recent Development | |
7 Recombinant Vaccines Manufacturing Cost Analysis |
|
7.1 Recombinant Vaccines Key Raw Materials Analysis |
|
| 7.1.1 Key Raw Materials | |
| 7.1.2 Key Raw Materials Price Trend | |
| 7.1.3 Key Suppliers of Raw Materials | |
7.2 Proportion of Manufacturing Cost Structure |
|
7.3 Manufacturing Process Analysis of Recombinant Vaccines |
|
7.4 Recombinant Vaccines Industrial Chain Analysis |
|
8 Marketing Channel, Distributors and Customers |
|
8.1 Marketing Channel |
|
8.2 Recombinant Vaccines Distributors List |
|
8.3 Recombinant Vaccines Customers |
|
9 Market Dynamics |
|
9.1 Market Trends |
|
9.2 Opportunities and Drivers |
|
9.3 Challenges |
|
9.4 Porter's Five Forces Analysis |
|
10 Global Market Forecast |
|
10.1 Global Recombinant Vaccines Market Estimates and Projections by Type |
|
| 10.1.1 Global Forecasted Sales of Recombinant Vaccines by Type (2021-2026) | |
| 10.1.2 Global Forecasted Revenue of Recombinant Vaccines by Type (2021-2026) | |
10.2 Recombinant Vaccines Market Estimates and Projections by Application |
|
| 10.2.1 Global Forecasted Sales of Recombinant Vaccines by Application (2021-2026) | |
| 10.2.2 Global Forecasted Revenue of Recombinant Vaccines by Application (2021-2026) | |
10.3 Recombinant Vaccines Market Estimates and Projections by Region |
|
| 10.3.1 Global Forecasted Sales of Recombinant Vaccines by Region (2021-2026) | |
| 10.3.2 Global Forecasted Revenue of Recombinant Vaccines by Region (2021-2026) | |
10.4 North America Recombinant Vaccines Estimates and Projections (2021-2026) |
|
10.5 Europe Recombinant Vaccines Estimates and Projections (2021-2026) |
|
10.6 Asia Pacific Recombinant Vaccines Estimates and Projections (2021-2026) |
|
10.7 Latin America Recombinant Vaccines Estimates and Projections (2021-2026) |
|
10.8 Middle East and Africa Recombinant Vaccines Estimates and Projections (2021-2026) |
|
11 Research Finding and Conclusion |
|
12 Methodology and Data Source |
|
12.1 Methodology/Research Approach |
|
| 12.1.1 Research Programs/Design | |
| 12.1.2 Market Size Estimation | |
| 12.1.3 Market Breakdown and Data Triangulation | |
12.2 Data Source |
|
| 12.2.1 Secondary Sources | |
| 12.2.2 Primary Sources | |
12.3 Author List |
|
12.4 Disclaimer |
|
| List of Tables | |
| Table 1. Global Recombinant Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026) | |
| Table 2. Global Recombinant Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026 | |
| Table 3. Global Recombinant Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026) | |
| Table 4. Global Key Recombinant Vaccines Manufacturers Covered in This Study | |
| Table 5. Global Recombinant Vaccines Sales (K Units) by Manufacturers (2015-2020) | |
| Table 6. Global Recombinant Vaccines Sales Share by Manufacturers (2015-2020) | |
| Table 7. Global Recombinant Vaccines Revenue (Million USD) by Manufacturers (2015-2020) | |
| Table 8. Global Recombinant Vaccines Revenue Share by Manufacturers (2015-2020) | |
| Table 9. Global Market Recombinant Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020) | |
| Table 10. Manufacturers Recombinant Vaccines Sales Sites and Area Served | |
| Table 11. Manufacturers Recombinant Vaccines Product Types | |
| Table 12. Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) | |
| Table 13. Global Recombinant Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Vaccines as of 2019) | |
| Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans | |
| Table 15. Main Points Interviewed from Key Recombinant Vaccines Players | |
| Table 16. Global Recombinant Vaccines Sales (K Units) by Region (2015-2020) | |
| Table 17. Global Recombinant Vaccines Sales Market Share by Region (2015-2020) | |
| Table 18. Global Recombinant Vaccines Revenue (Million US$) by Region (2015-2020) | |
| Table 19. Global Recombinant Vaccines Revenue Market Share by Region (2015-2020) | |
| Table 20. North America Recombinant Vaccines Sales by Country (2015-2020) (K Units) | |
| Table 21. North America Recombinant Vaccines Sales Market Share by Country (2015-2020) | |
| Table 22. North America Recombinant Vaccines Revenue by Country (2015-2020) (US$ Million) | |
| Table 23. North America Recombinant Vaccines Revenue Market Share by Country (2015-2020) | |
| Table 24. Europe Recombinant Vaccines Sales by Country (2015-2020) (K Units) | |
| Table 25. Europe Recombinant Vaccines Sales Market Share by Country (2015-2020) | |
| Table 26. Europe Recombinant Vaccines Revenue by Country (2015-2020) (US$ Million) | |
| 二〇二〇年至2026年全球重組疫苗市場的深入研究和趨勢分析報告 | |
| Table 27. Europe Recombinant Vaccines Revenue Market Share by Country (2015-2020) | |
| Table 28. Asia Pacific Recombinant Vaccines Sales by Region (2015-2020) (K Units) | |
| Table 29. Asia Pacific Recombinant Vaccines Sales Market Share by Region (2015-2020) | |
| Table 30. Asia Pacific Recombinant Vaccines Revenue by Region (2015-2020) (US$ Million) | |
| Table 31. Asia Pacific Recombinant Vaccines Revenue Market Share by Region (2015-2020) | |
| Table 32. Latin America Recombinant Vaccines Sales by Country (2015-2020) (K Units) | |
| Table 33. Latin America Recombinant Vaccines Sales Market Share by Country (2015-2020) | |
| Table 34. Latin America Recombinant Vaccines Revenue by Country (2015-2020) (US$ Million) | |
| Table 35. Latin America Recombinant Vaccines Revenue Market Share by Country (2015-2020) | |
| Table 36. Middle East and Africa Recombinant Vaccines Sales by Country (2015-2020) (K Units) | |
| Table 37. Middle East and Africa Recombinant Vaccines Sales Market Share by Country (2015-2020) | |
| Table 38. Middle East and Africa Recombinant Vaccines Revenue by Country (2015-2020) (US$ Million) | |
| Table 39. Middle East and Africa Recombinant Vaccines Revenue Market Share by Country (2015-2020) | |
| Table 40. Global Recombinant Vaccines Sales (K Units) by Type (2015-2020) | |
| Table 41. Global Recombinant Vaccines Sales Share by Type (2015-2020) | |
| Table 42. Global Recombinant Vaccines Revenue (Million US$) by Type (2015-2020) | |
| Table 43. Global Recombinant Vaccines Revenue Share by Type (2015-2020) | |
| Table 44. Global Recombinant Vaccines Price (USD/Unit) by Type (2015-2020) | |
| Table 45. Global Recombinant Vaccines Sales (K Units) by Application (2015-2020) | |
| Table 46. Global Recombinant Vaccines Sales Market Share by Application (2015-2020) | |
| Table 47. Global Recombinant Vaccines Sales Growth Rate by Application (2015-2020) | |
| Table 48. Company 1 Recombinant Vaccines Corporation Information | |
| Table 49. Company 1 Description and Business Overview | |
| Table 50. Company 1 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 51. Company 1 Main Product | |
| Table 52. Company 1 Recent Development | |
| Table 53. Company 2 Recombinant Vaccines Corporation Information | |
| Table 54. Company 2 Corporation Information | |
| Table 55. Company 2 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 56. Company 2 Main Product | |
| Table 57. Company 2 Recent Development | |
| Table 58. Company 3 Recombinant Vaccines Corporation Information | |
| Table 59. Company 3 Corporation Information | |
| Table 60. Company 3 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 61. Company 3 Main Product | |
| Table 62. Company 3 Recent Development | |
| Table 63. Company 4 Recombinant Vaccines Corporation Information | |
| Table 64. Company 4 Corporation Information | |
| Table 65. Company 4 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 66. Company 4 Main Product | |
| Table 67. Company 4 Recent Development | |
| Table 68. Company 5 Recombinant Vaccines Corporation Information | |
| Table 69. Company 5 Corporation Information | |
| Table 70. Company 5 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 71. Company 5 Main Product | |
| Table 72. Company 5 Recent Development | |
| Table 73. Company 6 Recombinant Vaccines Corporation Information | |
| Table 74. Company 6 Corporation Information | |
| Table 75. Company 6 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 76. Company 6 Main Product | |
| Table 77. Company 6 Recent Development | |
| Table 78. Company 7 Recombinant Vaccines Corporation Information | |
| Table 79. Company 7 Corporation Information | |
| Table 80. Company 7 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 81. Company 7 Main Product | |
| Table 82. Company 7 Recent Development | |
| Table 83. Company 8 Recombinant Vaccines Corporation Information | |
| Table 84. Company 8 Corporation Information | |
| Table 85. Company 8 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 86. Company 8 Main Product | |
| Table 87. Company 8 Recent Development | |
| Table 88. Company 9 Recombinant Vaccines Corporation Information | |
| Table 89. Company 9 Corporation Information | |
| Table 90. Company 9 Recombinant Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) | |
| Table 91. Company 9 Main Product | |
| Table 92. Company 9 Recent Development | |
| Table 93. Sales Base and Market Concentration Rate of Raw Material | |
| Table 94. Key Suppliers of Raw Materials | |
| Table 95. Recombinant Vaccines Distributors List | |
| Table 96. Recombinant Vaccines Customers List | |
| Table 97. Market Key Trends | |
| Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026) | |
| Table 99. Key Challenges | |
| Table 100. Global Recombinant Vaccines Sales (K Units) Forecast by Type (2021-2026) | |
| Table 101. Global Recombinant Vaccines Sales Market Share Forecast by Type (2021-2026) | |
| Table 102. Global Recombinant Vaccines Revenue (Million US$) Forecast by Type (2021-2026) | |
| Table 103. Global Recombinant Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026) | |
| Table 104. Global Recombinant Vaccines Sales (K Units) Forecast by Application (2021-2026) | |
| Table 105. Global Recombinant Vaccines Revenue (Million US$) Forecast by Application (2021-2026) | |
| Table 106. Global Recombinant Vaccines Sales (K Units) Forecast by Region (2021-2026) | |
| Table 107. Global Recombinant Vaccines Sales Market Share Forecast by Region (2021-2026) | |
| èr líng èr líng nián zhì 2026 nián quánqiú chóngzǔ yìmiáo shìchǎng de shēnrù yánjiū hé qūshì fēnxī bàogào | |
| Table 108. Global Recombinant Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) | |
| Table 109. Global Recombinant Vaccines Revenue Market Share Forecast by Region (2021-2026) | |
| Table 110. Research Programs/Design for This Report | |
| Table 111. Key Data Information from Secondary Sources | |
| Table 112. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Picture of Recombinant Vaccines | |
| Figure 2. Global Recombinant Vaccines Sales Market Share by Type: 2020 VS 2026 | |
| Figure 3. Subunit Recombinant Vaccines Product Picture | |
| Figure 4. Attenuated Recombinant Vaccines Product Picture | |
| Figure 5. Vector Recombinant Vaccines Product Picture | |
| Figure 6. Global Recombinant Vaccines Consumption Market Share by Application: 2020 VS 2026 | |
| Figure 7. Recombinant Human Vaccines | |
| Figure 8. Animal Recombinant Vaccines | |
| Figure 9. Global Recombinant Vaccines Market Size 2015-2026 (US$ Million) | |
| Figure 10. Global Recombinant Vaccines Sales Capacity (K Units) (2015-2026) | |
| Figure 11. Global Recombinant Vaccines Market Size Market Share by Region: 2020 Versus 2026 | |
| Figure 12. Recombinant Vaccines Sales Share by Manufacturers in 2020 | |
| Figure 13. Global Recombinant Vaccines Revenue Share by Manufacturers in 2019 | |
| Figure 14. The Global 5 and 10 Largest Players: Market Share by Recombinant Vaccines Revenue in 2019 | |
| Figure 15. Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 | |
| Figure 16. Global Recombinant Vaccines Sales Market Share by Region (2015-2020) | |
| Figure 17. Global Recombinant Vaccines Sales Market Share by Region in 2019 | |
| Figure 18. Global Recombinant Vaccines Revenue Market Share by Region (2015-2020) | |
| Figure 19. Global Recombinant Vaccines Revenue Market Share by Region in 2019 | |
| Figure 20. North America Recombinant Vaccines Sales Market Share by Country in 2019 | |
| Figure 21. North America Recombinant Vaccines Revenue Market Share by Country in 2019 | |
| Figure 22. U.S. Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 23. U.S. Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 24. Canada Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 25. Canada Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 26. Europe Recombinant Vaccines Sales Market Share by Country in 2019 | |
| Figure 27. Europe Recombinant Vaccines Revenue Market Share by Country in 2019 | |
| Figure 28. Germany Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 29. Germany Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 30. France Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 31. France Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 32. U.K. Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 33. U.K. Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 34. Italy Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 35. Italy Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 36. Russia Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 37. Russia Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 38. Asia Pacific Recombinant Vaccines Sales Market Share by Region in 2019 | |
| Figure 39. Asia Pacific Recombinant Vaccines Revenue Market Share by Region in 2019 | |
| Figure 40. China Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 41. China Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 42. Japan Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 43. Japan Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 44. South Korea Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 45. South Korea Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 46. India Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 47. India Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 48. Australia Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 49. Australia Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 50. Taiwan, China Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 51. Taiwan, China Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 52. Indonesia Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 53. Indonesia Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 54. Thailand Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 55. Thailand Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 56. Malaysia Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 57. Malaysia Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 58. Philippines Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 59. Philippines Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 60. Vietnam Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 61. Vietnam Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 62. Latin America Recombinant Vaccines Sales Market Share by Country in 2019 | |
| Figure 63. Latin America Recombinant Vaccines Revenue Market Share by Country in 2019 | |
| Figure 64. Mexico Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 65. Mexico Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 66. Brazil Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 67. Brazil Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 68. Argentina Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 69. Argentina Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 70. Middle East and Africa Recombinant Vaccines Sales Market Share by Country in 2019 | |
| Figure 71. Middle East and Africa Recombinant Vaccines Revenue Market Share by Country in 2019 | |
| 2020-2026グローバル組換えワクチン市場の深い研究と動向分析レポート | |
| Figure 72. Turkey Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 73. Turkey Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 74. Saudi Arabia Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 75. Saudi Arabia Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 76. U.A.E Recombinant Vaccines Sales Growth Rate (2015-2020) (K Units) | |
| Figure 77. U.A.E Recombinant Vaccines Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 78. Sales Market Share of Recombinant Vaccines by Type (2015-2020) | |
| Figure 79. Sales Market Share of Recombinant Vaccines by Type in 2019 | |
| Figure 80. Revenue Share of Recombinant Vaccines by Type (2015-2020) | |
| Figure 81. Revenue Market Share of Recombinant Vaccines by Type in 2019 | |
| Figure 82. Global Recombinant Vaccines Sales Growth by Type (2015-2020) (K Units) | |
| Figure 83. Global Recombinant Vaccines Sales Market Share by Application (2015-2020) | |
| Figure 84. Global Recombinant Vaccines Sales Market Share by Application in 2019 | |
| Figure 85. Global Revenue Share of Recombinant Vaccines by Application (2015-2020) | |
| Figure 86. Global Revenue Share of Recombinant Vaccines by Application in 2020 | |
| Figure 87. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 88. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 89. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 90. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 91. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 92. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 93. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 94. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 95. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 96. Price Trend of Key Raw Materials | |
| Figure 97. Manufacturing Cost Structure of Recombinant Vaccines | |
| Figure 98. Manufacturing Process Analysis of Recombinant Vaccines | |
| Figure 99. Recombinant Vaccines Industrial Chain Analysis | |
| Figure 100. Channels of Distribution | |
| Figure 101. Distributors Profiles | |
| Figure 102. Porter's Five Forces Analysis | |
| Figure 103. North America Recombinant Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) | |
| Figure 104. North America Recombinant Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 105. Europe Recombinant Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) | |
| Figure 106. Europe Recombinant Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 107. Latin America Recombinant Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) | |
| Figure 108. Latin America Recombinant Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 109. Middle East and Africa Recombinant Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) | |
| Figure 110. Middle East and Africa Recombinant Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 111. Asia Pacific Recombinant Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) | |
| Figure 112. Asia Pacific Recombinant Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 113. Bottom-up and Top-down Approaches for This Report | |
| Figure 114. Data Triangulation | |
| Figure 115. Key Executives Interviewed | |
略……
如需購買《2020-2026 Global Recombinant Vaccines Market In-Depth Research and Trends Analysis Report》，編號：2737690
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號